Dissanaike Sharmila 4
4 · HERON THERAPEUTICS, INC. /DE/ · Filed Dec 20, 2022
Insider Transaction Report
Form 4
Dissanaike Sharmila
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-12-16+77,160→ 77,160 totalExercise: $2.74Exp: 2032-12-16→ Common Stock (77,160 underlying) - Award
Common Stock
2022-12-16+38,580→ 55,282 total
Footnotes (2)
- [F1]The shares were granted as restricted stock units which vest in full on December 16, 2023.
- [F2]The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant.